Who owns BIOXCEL THERAPEUTICS INC COM NEW?
- Ticker: BTAI
- CUSIP Number: 09075p204
Tip: Access positions for across all investors
Analyze quarterly positions in Bioxcel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioxcel Therapeutics stock
Who bought or sold BIOXCEL THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 1.9M | $2.6M | 6% | Mar 2026 |
|
| Armistice Capital | 1.9M | $2.6M | 100% | Mar 2026 |
|
| Vanguard Group | 293k | $468k | 52% | Dec 2025 |
|
| Oaktree Capital Management | 241k | $323k | 0% | Mar 2026 |
|
| Geode Capital Management | 230k | $309k | 12% | Mar 2026 |
|
| Vanguard Capital Management | 207k | $278k | 100% | Mar 2026 |
|
| Jones Financial Companies, L.L | 138k | $220k | 282% | Dec 2025 |
|
| Man Group | 97k | $129k | 70% | Mar 2026 |
|
| FMR | 90k | $145k | -55% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 85k | $114k | 100% | Mar 2026 |
|
| BlackRock | 84k | $113k | 0% | Mar 2026 |
|
| State Street Corporation | 63k | $101k | 20% | Dec 2025 |
|
| UBS Group | 53k | $71k | 38% | Mar 2026 |
|
| Oaktree Fund Advisors | 43k | $58k | 0% | Mar 2026 |
|
| HighTower Advisors | 41k | $55k | 0% | Mar 2026 |
|
| Northern Trust | 38k | $61k | 2% | Dec 2025 |
|
| Advisor Group Holdings | 16k | $25k | 4% | Dec 2025 |
|
| Diversify Wealth Management | 15k | $16k | 0% | Mar 2026 |
|
| Engineers Gate Manager | 12k | $20k | 100% | Dec 2025 |
|
| Portfolio Strategies | 12k | $16k | 0% | Mar 2026 |
|
| Morgan Stanley | 11k | $14k | 623% | Mar 2026 |
|
| Wells Fargo & Company | 4.3k | $5.8k | 0% | Mar 2026 |
|
| Goss Wealth Management | 1.3k | $1.8k | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 493.00 | $661.014400 | 100% | Mar 2026 |
|
| Silver Grove Financial Group | 334.00 | $446.992200 | 100% | Mar 2026 |
|
| Washington Trust Advisors | 160.00 | $214.000000 | 0% | Mar 2026 |
|
| Annis Gardner Whiting Capital Advisors | 156.00 | $210.007200 | 39% | Mar 2026 |
|
| Parkside Financial Bank & Trust | 112.00 | $150.998400 | 0% | Mar 2026 |
|
| EverSource Wealth Advisors | 60.00 | $79.998000 | 0% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 59.00 | $79.001000 | 392% | Mar 2026 |
|
| Farther Finance Advisors | 25.00 | $31.000000 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 21.00 | $27.999300 | 0% | Mar 2026 |
|
| SBI Securities | 14.00 | $18.999400 | -92% | Mar 2026 |
|
| IFP Advisors | 13.00 | $17.000100 | -100% | Mar 2026 |
|
| Zurcher Kantonalbank | 2.00 | $3.000000 | 0% | Mar 2026 |
|
| Triumph Capital Management | 1.00 | $1.000000 | 0% | Mar 2026 |
|
| Group One Trading | 1.00 | $1.000000 | -100% | Mar 2026 |
|
| Us Bancorp | 1.00 | $2.000000 | 0% | Dec 2025 |
|
Who sold out of Bioxcel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Dec 2025 | 128k | $204k |
| GSA Capital Partners | Dec 2025 | 120k | $192k |
| XTX Topco | Sep 2025 | 113k | $290k |
| Hrt Financial | Dec 2025 | 18k | $28k |
| Two Sigma Securities | Dec 2025 | 17k | $27k |
| Tower Research Capital | Sep 2025 | 3.9k | $10k |
| Caitong International Asset Management | Dec 2025 | 1.6k | $2.6k |
| Jpmorgan Chase & Co | Sep 2025 | 45.00 | $115.002000 |